BioSpace News Archive

BeiGene, Ltd. announced that the China National Medical Products Administration has conditionally approved KYPROLIS® for injection in combination with dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least two prior therapies, including a proteasome inhibitor and an immunomodulatory agent.

According to the report, the global laparoscopy devices market was valued at US$ 8.5 Bn in 2019 and is projected to expand at a CAGR of 6.5% from 2020 to 2030.

According to the report, the global DNA test kits market was valued at ~US$ 712 Mn in 2019. It is projected to expand at a CAGR of ~16% from 2020 to 2030. DNA test kits are used to collect saliva, which enables the laboratory to extract DNA from it.

Transparency Market Research has published a new report titled, ‘Dental Implants Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

The Fact.MR analysis on anticoagulants market provides insights into factors enabling sales across various segments in the market including drug class, indication and sales channels.

Artificial intelligence and machine learning technologies are showing an incredible potential in improving clinical research and development productivity.

The expansion of the global biopharmaceutical third party logistics market is estimated to be driven by growing trend of outsourcing logistics.

Sequanta Technologies Co., Ltd. (“Sequanta”) and Mission Bio. (“Mission Bio”) are pleased to announce that they have entered into a strategic partnership, providing high-quality single-cell sequence services using Mission Bio’s products to customers in mainland China .

Kaneka Corporation received U.S.-FDA*1approval in April 2020 for its new brain aneurysm Embolization Coil*2,and has been marketing it through Kaneka Medical America LLC*3 since September 2020.

CTI BioPharma Corp. announced that an authorized subcommittee of the Compensation Committee of its Board of Directors granted an equity award to a new employee as an equity inducement award outside of the Company’s Amended and Restated 2017 Equity Incentive Plan and material to the employee’s acceptance of employment with the company.